Amneal Pharmaceuticals, Inc. AMRX

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $16.88
Market Cap $5.38B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑8.0% YoY
$3.02B
3-Yr CAGR: 10.9%
Net Income ↑273.2% YoY
$127.93M
Net Margin: 4.2%
Free Cash Flow ↑11.0% YoY
$269.93M
FCF Yield: 5.02%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: 3.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AMRX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $1,033.7M $526.2M $169.3M $234.2M $139.4M
FY 2018 $1,663.0M +60.9% $716.4M $-201.3M -218.9% 0.00% $250.2M $167.1M +19.9%
FY 2019 $1,626.4M -2.2% $353.0M $-603.6M -199.8% 0.00% $1.7M $-45.5M -127.2%
FY 2020 $1,992.5M +22.5% $628.4M $68.6M +111.4% 0.00% $379.0M $322.6M +809.3%
FY 2021 $2,093.7M +5.1% $769.0M $20.2M -70.6% 0.00% $241.8M $194.1M -39.8%
FY 2022 $2,212.3M +5.7% $784.7M $-254.8M -1,363.2% 0.00% $65.1M $18.7M -90.4%
FY 2023 $2,393.6M +8.2% $820.6M $-48.7M +80.9% 0.00% $345.6M $302.4M +1,517.5%
FY 2024 $2,794.0M +16.7% $1,020.4M $-73.9M -51.6% 0.00% $295.1M $243.2M -19.6%
FY 2025 $3,018.8M +8.0% $1,113.3M $127.9M +273.2% 0.00% $340.0M $269.9M +11.0%
$

Valuation

Market Price $16.88
Market Cap $5.38B
Enterprise Value $7.67B
P/E Ratio N/A
P/B Ratio N/A
FCF Yield 5.02%
Dividend Yield N/A
Shares Outstanding 319,022,800
%

Profitability & Margins

Gross Margin 36.88%
Operating Margin 13.05%
Net Margin 4.24%
Return on Equity (ROE) N/A
Return on Assets (ROA) 3.48%
Asset Turnover 0.82x
Revenue 3-Yr CAGR 10.92%
🛡️

Financial Health & Liquidity

Current Ratio 0.11
Cash Ratio 0.32
Debt / Equity N/A
Debt / Assets 0.699
Cash & Equivalents $282.03M
Total Debt $2.57B
Book Value / Share N/A
💧

Cash Flow Efficiency

Operating Cash Flow $339.99M
Capital Expenditures (CapEx) $70.06M
Free Cash Flow $269.93M
OCF / Revenue 11.26%
FCF / Revenue 8.94%
FCF 3-Yr CAGR 143.51%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share N/A
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $3.68B
Total Liabilities $3.68B
Stockholders' Equity N/A
Current Assets $98.39M
Current Liabilities $881.63M